{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-022184","form_type":"8-K","ticker":"SCNX","cik":"0001382574","company_name":"Scienture Holdings, Inc.","filed_at":"2023-06-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.653700+00:00","generated_at":"2026-06-13T17:48:03.369660+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"TRxADE Health signs binding LOI to acquire Superlatus, pivoting to food technology","bullets":["Superlatus shareholders receive 30,821,918 MEDS shares valued at $7.30 per share, comprising 19.99% of post-merger common stock and remainder in non-voting preferred.","Merger conditions include Superlatus acquiring Sapientia and Prestige Farms; combined valuation target of at least $225M.","TRxADE plans to divest its existing pharmaceutical exchange business after closing.","Expected close in late Q3 or early Q4 2023, subject to due diligence, audited financials, Nasdaq approval.","Board of both companies unanimously approved LOI."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-022184","json":"https://secwatch.observer/filing/0001493152-23-022184.json","markdown":"https://secwatch.observer/filing/0001493152-23-022184.md","text":"https://secwatch.observer/filing/0001493152-23-022184.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223022184/0001493152-23-022184-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223022184/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T17:48:03.369660+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"73c88d77509928cfaacd7ceae85a823d5b62d067","claim":"Scienture Holdings, Inc. entered into LOI with Superlatus, Inc. (effective 2023-06-22).","evidence_excerpt":"On June 22, 2023, TRxADE HEALTH, INC. (the \"Company\") entered into a binding letter of intent (\"LOI\") for a merger (the \"Merger\") with Superlatus, Inc., a U.S.-based holding company of food products and distribution capabilities (\"Superlatus\").","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223022184/0001493152-23-022184-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"merger"},{"label":"Counterparty","value":"Superlatus, Inc."},{"label":"Effective","value":"2023-06-22"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}